Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2018, Article ID 6548715, 8 pages
https://doi.org/10.1155/2018/6548715
Research Article

Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study

1UOC di Reumatologia, Azienda Ospedaliero-Universitaria di Sassari, Sassari, Italy
2UOC di Reumatologia, Policlinico Universitario di Monserrato, Cagliari, Italy
3UOC di Reumatologia, Fondazione Policlinico Universitario A. Gemelli-Catholic University of the Sacred Heart, Roma, Italy
4Department of Clinical Pharmacology, Flinders University and Flinders Medical Centre, Adelaide, Australia
5UO di Cardiologia, Azienda Ospedaliero-Universitaria di Sassari, Sassari, Italy
6Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy

Correspondence should be addressed to Gian Luca Erre; ti.orebil@aculnaig.e

Received 26 July 2017; Revised 27 October 2017; Accepted 12 November 2017; Published 1 February 2018

Academic Editor: Shin-ichi Yokota

Copyright © 2018 Gian Luca Erre et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Naz and D. P. Symmons, “Mortality in established rheumatoid arthritis,” Best Practice & Research Clinical Rheumatology, vol. 21, no. 5, pp. 871–883, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. H. Humphreys, A. Warner, J. Chipping et al., “Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register,” Arthritis Care & Research, vol. 66, no. 9, pp. 1296–1301, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. N. J. Goodson, N. J. Wiles, M. Lunt, E. M. Barrett, A. J. Silman, and D. P. Symmons, “Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients,” Arthritis & Rheumatism, vol. 46, no. 8, pp. 2010–2019, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Aviña-Zubieta, H. K. Choi, M. Sadatsafavi, M. Etminan, J. M. Esdaile, and D. Lacaille, “Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies,” Arthritis & Rheumatism, vol. 59, no. 12, pp. 1690–1697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Gonzalez, H. Maradit Kremers, C. S. Crowson et al., “The widening mortality gap between rheumatoid arthritis patients and the general population,” Arthritis & Rheumatism, vol. 56, no. 11, pp. 3583–3587, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. I. D. del Rincón, K. Williams, M. P. Stern, G. L. Freeman, and A. Escalante, “High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors,” Arthritis & Rheumatism, vol. 44, no. 12, pp. 2737–2745, 2001. View at Publisher · View at Google Scholar
  7. A. Gonzalez, H. Maradit Kremers, C. S. Crowson et al., “Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?” Annals of the Rheumatic Diseases, vol. 67, no. 1, pp. 64–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. G. L. Erre, A. Piras, S. Mura et al., “Asymmetric dimethylarginine and arterial stiffness in patients with rheumatoid arthritis: a case–control study,” Journal of International Medical Research, vol. 44, Supplement 1, pp. 76–80, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Vaudo, S. Marchesi, R. Gerli et al., “Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity,” Annals of the Rheumatic Diseases, vol. 63, no. 1, pp. 31–35, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. P. O. Bonetti, L. O. Lerman, and A. Lerman, “Endothelial dysfunction: a marker of atherosclerotic risk,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 2, pp. 168–175, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Lind, L. Berglund, A. Larsson, and J. Sundström, “Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease,” Circulation, vol. 123, no. 14, pp. 1545–1551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Sandoo, J. J. C. S. Veldhuijzen van Zanten, G. S. Metsios, D. Carroll, and G. D. Kitas, “Vascular function and morphology in rheumatoid arthritis: a systematic review,” Rheumatology, vol. 50, no. 11, pp. 2125–2139, 2011. View at Publisher · View at Google Scholar
  13. A. Sandoo, D. Carroll, G. S. Metsios, G. D. Kitas, and J. J. Veldhuijzen van Zanten, “The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study,” Arthritis Research & Therapy, vol. 13, no. 3, article R99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. P. O. Bonetti, G. M. Pumper, S. T. Higano, D. R. Holmes Jr., J. T. Kuvin, and A. Lerman, “Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia,” Journal of the American College of Cardiology, vol. 44, no. 11, pp. 2137–2141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. N. M. Hamburg, M. J. Keyes, M. G. Larson et al., “Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study,” Circulation, vol. 117, no. 19, pp. 2467–2474, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Matsuzawa, S. Sugiyama, K. Sugamura et al., “Digital assessment of endothelial function and ischemic heart disease in women,” Journal of the American College of Cardiology, vol. 55, no. 16, pp. 1688–1696, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Matsuzawa, S. Sugiyama, H. Sumida et al., “Peripheral endothelial function and cardiovascular events in high-risk patients,” Journal of the American Heart Association, vol. 2, no. 6, article e000426, 2013. View at Publisher · View at Google Scholar
  18. Y. Matsuzawa, T. G. Kwon, R. J. Lennon, L. O. Lerman, and A. Lerman, “Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysisJournal of the American Heart Association,” vol. 4, no. 11, article e002270, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Hjeltnes, I. Hollan, Ø. Førre, A. Wiik, K. Mikkelsen, and S. Agewall, “Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients,” Scandinavian Journal of Rheumatology, vol. 40, no. 6, pp. 422–427, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Aletaha, T. Neogi, A. J. Silman et al., “2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative,” Annals of the Rheumatic Diseases, vol. 69, no. 9, pp. 1580–1588, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. N. M. Hamburg, J. Palmisano, M. G. Larson et al., “Relation of brachial and digital measures of vascular function in the community: the Framingham Heart Study,” Hypertension, vol. 57, no. 3, pp. 390–396, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. R. B. Schnabel, A. Schulz, P. S. Wild et al., “Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods,” Circulation: Cardiovascular Imaging, vol. 4, no. 4, pp. 371–380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Aizer, E. W. Karlson, L. B. Chibnik et al., “A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus,” Lupus, vol. 18, no. 3, pp. 235–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Rubinshtein, J. T. Kuvin, M. Soffler et al., “Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events,” European Heart Journal, vol. 31, no. 9, pp. 1142–1148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. E. McClendon, S. K. Musani, T. E. Samdarshi et al., “The relation of digital vascular function to cardiovascular risk factors in African-Americans using digital tonometry: the Jackson Heart Study,” Journal of The American Society of Hypertension, vol. 11, no. 6, pp. 325–333.e2, 2017. View at Publisher · View at Google Scholar
  26. C. R. Lee, A. Bass, K. Ellis et al., “Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteers,” The American Journal of Cardiology, vol. 109, no. 5, pp. 651–657, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Choy, K. Ganeshalingam, A. G. Semb, Z. Szekanecz, and M. Nurmohamed, “Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment,” Rheumatology, vol. 53, no. 12, pp. 2143–2154, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Myasoedova, C. S. Crowson, H. M. Kremers et al., “Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease,” Annals of Rheumatic Diseases, vol. 70, no. 3, pp. 482–487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. J. R. Nofer, M. van der Giet, M. Tölle et al., “HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3,” The Journal of Clinical Investigation, vol. 113, no. 4, pp. 569–581, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Ferré, G. Aragonès, N. Plana et al., “High-density lipoprotein cholesterol and apolipoprotein A1 levels strongly influence the reactivity of small peripheral arteries,” Atherosclerosis, vol. 216, no. 1, pp. 115–119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Aragonès, R. Ferré, J. Girona et al., “Small artery dilation and endothelial markers in cardiovascular risk patients,” European Journal of Clinical Investigation, vol. 42, no. 1, pp. 34–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. G. G. Ristić, T. Lepić, B. Glisić et al., “Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment,” Rheumatology, vol. 49, no. 6, pp. 1076–1081, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Vandhuick, Y. Allanore, D. Borderie et al., “Early phase clinical and biological markers associated with subclinical atherosclerosis measured at 7 years of evolution in an early inflammatory arthritis cohort,” Clinical and Experimental Rheumatology, vol. 34, no. 1, pp. 58–67, 2016. View at Google Scholar
  34. F. J. Lopez-Longo, D. Oliver-Minarro, I. de la Torre et al., “Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis,” Arthritis Care & Research, vol. 61, no. 4, pp. 419–424, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Innala, B. Moller, L. Ljung et al., “Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study,” Arthritis Research & Therapy, vol. 13, no. 4, article R131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. K. P. Liang, H. M. Kremers, C. S. Crowson et al., “Autoantibodies and the risk of cardiovascular events,” The Journal of Rheumatology, vol. 36, no. 11, pp. 2462–2469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. B. R. England, H. Sayles, K. Michaud et al., “Cause-specific mortality in male US veterans with rheumatoid arthritis,” Arthritis Care & Research, vol. 68, no. 1, pp. 36–45, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. L. J. Barra, J. E. Pope, C. Hitchon et al., “The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis,” Rheumatology, vol. 56, no. 1, article 28073956, pp. 768–776, 2017. View at Publisher · View at Google Scholar · View at Scopus